Page 1 | Search Results | Diabetes | American Diabetes Association

1-20 of 44

Sort by

Sort Order Select

Meeting Abstracts

913-P: Risk of Dementia in Diabetes Patients Aged Less than 70 Years Initiating Sodium–Glucose Cotransporter-2 Inhibitor vs. Dipeptidyl-Peptidase-4 Inhibitor

ANNA SHIN, BO KYUNG KOO, JUN-YOUNG LEE, EUN HA KANG

Diabetes 2024;73(Supplement_1):913-P

https://doi.org/10.2337/db24-913-P

Published: 14 June 2024

View article titled, 913-P: Risk of Dementia in Diabetes Patients Aged Less than 70 Years Initiating Sodium–Glucose Cotransporter-2 Inhibitor vs. Dipeptidyl-Peptidase-4 Inhibitor

Meeting Abstracts

420-P: Effects of Nonalbuminuric Type 2 Diabetes Mellitus on Renal Outcomes

DUGHYUN CHOI, SAMEL PARK, EUN YOUNG LEE

Diabetes 2024;73(Supplement_1):420-P

https://doi.org/10.2337/db24-420-P

Published: 14 June 2024

View article titled, 420-P: Effects of Nonalbuminuric Type 2 Diabetes Mellitus on Renal Outcomes

Meeting Abstracts

426-P: Association of Succinate and Adenosine Nucleotide Metabolic Pathways with the Progression of Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus

INHA JUNG, SEUNGYOON NAM, SOYOUNG PARK, DA YOUNG LEE, JI HEE YU, JI A SEO, DAE HO LEE, NAN HEE KIM

Diabetes 2024;73(Supplement_1):426-P

https://doi.org/10.2337/db24-426-P

Published: 14 June 2024

View article titled, 426-P: Association of Succinate and Adenosine Nucleotide Metabolic Pathways with the Progression of Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus

Meeting Abstracts

452-P: Risk of Cardiovascular Disease according to Baseline LDL Cholesterol Level in Different Age Groups among 2 Million Diabetes Patients

WON-YOUNG LEE, EUN-JUNG RHEE, KYUNGDO HAN

Diabetes 2023;72(Supplement_1):452-P

https://doi.org/10.2337/db23-452-P

Published: 20 June 2023

View article titled, 452-P: Risk of Cardiovascular Disease according to Baseline LDL Cholesterol Level in Different Age Groups among 2 Million Diabetes Patients

Meeting Abstracts

890-P: Efficacy and Safety of Dapagliflozin Add-on Therapy to Evogliptin plus Metformin Combinations in Inadequately Controlled Patients with Type 2 Diabetes—A 24-Week, Randomized, Double-blind, Placebo-Controlled, Parallel-Design, Phase 3 Trial

IN-KYUNG JEONG, KYUNG MOOK CHOI, KYUNG AH HAN, KYOUNG-AH KIM, IN JOO KIM, SEUNG JIN HAN, WON-YOUNG LEE, SOON JIB YOO

Diabetes 2023;72(Supplement_1):890-P

https://doi.org/10.2337/db23-890-P

Published: 20 June 2023

View article titled, 890-P: Efficacy and Safety of Dapagliflozin Add-on Therapy to Evogliptin plus Metformin Combinations in Inadequately Controlled Patients with Type 2 Diabetes—A 24-Week, Randomized, Double-blind, Placebo-Controlled, Parallel-Design, Phase 3 Trial

Meeting Abstracts

253-LB: Characterization of Korean Type 2 Diabetes as Hyperinsulinemic, Insulin-Resistant, and miR-10a/b-5p-Deficient Hyperglycemia

TAE YANG YU, MIN-SEOB KIM, SE EUN HA, RAJAN SINGH, DAHYUN SEON, JIN WOO JEONG, MOON YOUNG LEE, SEUNGIL RO

Diabetes 2023;72(Supplement_1):253-LB

https://doi.org/10.2337/db23-253-LB

Published: 20 June 2023

View article titled, 253-LB: Characterization of Korean Type 2 Diabetes as Hyperinsulinemic, Insulin-Resistant, and miR-10a/b-5p-Deficient Hyperglycemia

Meeting Abstracts

1432-P: Lipid Profile and Visit-to-Visit Variability of LDL Cholesterol, the Association with Risk of Young-Onset Type 2 Diabetes—Nationwide Retrospective Cohort Study

MI HAE SEO, SE EUN PARK, EUN-JUNG RHEE, WON-YOUNG LEE

Diabetes 2023;72(Supplement_1):1432-P

https://doi.org/10.2337/db23-1432-P

Published: 20 June 2023

View article titled, 1432-P: Lipid Profile and Visit-to-Visit Variability of LDL Cholesterol, the Association with Risk of Young-Onset Type 2 Diabetes—Nationwide Retrospective Cohort Study

Meeting Abstracts

975-P: Clinical and Lifestyle Determinants of Continuous Glucose Monitoring Metrics in Insulin-Treated Patients with Type 2 Diabetes

DA YOUNG LEE, NAMHO KIM, INHA JUNG, SO YOUNG PARK, JI HEE YU, JI A SEO, SUNG-MIN PARK, NAN HEE KIM

Diabetes 2023;72(Supplement_1):975-P

https://doi.org/10.2337/db23-975-P

Published: 20 June 2023

View article titled, 975-P: Clinical and Lifestyle Determinants of Continuous Glucose Monitoring Metrics in Insulin-Treated Patients with Type 2 Diabetes

Meeting Abstracts

765-P: DA-1241, a Novel GPR119 Agonist: Data on Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) from Part 2 of a Phase 1b Multiple Ascending Dose (MAD) Study in Patients with Type 2 Diabetes Mellitus (T2DM)

MI-KYUNG KIM, DAE YOUNG LEE, JIYOON JEONG, MICHAEL GRIMM, BRIDGETTE B. FRANEY, MARCUS HOMPESCH

Diabetes 2021;70(Supplement_1):765-P

https://doi.org/10.2337/db21-765-P

Published: 01 June 2021

View article titled, 765-P: DA-1241, a Novel GPR119 Agonist: Data on Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) from Part 2 of a Phase 1b Multiple Ascending Dose (MAD) Study in Patients with Type 2 Diabetes Mellitus (T2DM)

Meeting Abstracts

766-P: DA-1241, a Novel GPR119 Agonist: Data on Safety, Tolerability, and Pharmacokinetics (PK) from Part 1 of a Phase 1b Multiple Ascending Dose (MAD) Study in Healthy Volunteers (HV)

MI-KYUNG KIM, DAE YOUNG LEE, JIYOON JEONG, MICHAEL GRIMM, BRIDGETTE B. FRANEY, MARCUS HOMPESCH

Diabetes 2021;70(Supplement_1):766-P

https://doi.org/10.2337/db21-766-P

Published: 01 June 2021

View article titled, 766-P: DA-1241, a Novel GPR119 Agonist: Data on Safety, Tolerability, and Pharmacokinetics (PK) from Part 1 of a Phase 1b Multiple Ascending Dose (MAD) Study in Healthy Volunteers (HV)

Meeting Abstracts

868-P: The Efficacy of Personalized Diabetes Management Using an Electronic Medical Record-Integrated Mobile Application

JAE-SEUNG YUN, SUN-YOUNG LIM, SEON-AH CHA, KUN-HO YOON, YU-BAE AHN, EUN YOUNG LEE, SEUNG-HYUN KO

Diabetes 2021;70(Supplement_1):868-P

https://doi.org/10.2337/db21-868-P

Published: 01 June 2021

View article titled, 868-P: The Efficacy of Personalized Diabetes Management Using an Electronic Medical Record-Integrated Mobile Application

Meeting Abstracts

352-P: Assessment of a Deep Learning Model Based on Three-Year Longitudinal Electronic Health Record Data for Predicting Severe Hypoglycemia in Patients with Type 2 Diabetes

GARAM LEE, SEUNG-HYUN KO, YU-BAE AHN, EUN YOUNG LEE, SEON-AH CHA, DOKYOON KIM, JAE-SEUNG YUN

Diabetes 2021;70(Supplement_1):352-P

https://doi.org/10.2337/db21-352-P

Published: 01 June 2021

View article titled, 352-P: Assessment of a Deep Learning Model Based on Three-Year Longitudinal Electronic Health Record Data for Predicting Severe Hypoglycemia in Patients with Type 2 Diabetes

Meeting Abstracts

2289-PUB: Comparison of GalT-KO Porcine Islet Xenograft Survival between Microcapsule against Hypoxia and Microcapsule against Fibrosis in Diabetic Mice Model

EUN YOUNG LEE, YEOREE YANG, YUNJUNG CHO, SEUNG-HWAN LEE, JAE-HYOUNG CHO, KUN-HO YOON

Diabetes 2020;69(Supplement_1):2289-PUB

https://doi.org/10.2337/db20-2289-PUB

Published: 01 June 2020

View article titled, 2289-PUB: Comparison of GalT-KO Porcine Islet Xenograft Survival between Microcapsule against Hypoxia and Microcapsule against Fibrosis in Diabetic Mice Model

Meeting Abstracts

2176-P: miRNA-374 Improves Glucotoxicity-Induced Beta-Cell Dysfunction and Glucose Metabolism Dysfunction through the Regulation of PGC-1 Alpha

JIWON KIM, YOUNG HYE YOU, EUN YOUNG LEE, KUN-HO YOON

Diabetes 2019;68(Supplement_1):2176-P

https://doi.org/10.2337/db19-2176-P

Published: 01 June 2019

View article titled, 2176-P: miRNA-374 Improves Glucotoxicity-Induced Beta-Cell Dysfunction and Glucose Metabolism Dysfunction through the Regulation of PGC-1 Alpha

Meeting Abstracts

17-LB: Prognostic Value of Gamma-Glutamyl Transferase Variability in Individuals with Diabetes: A Nationwide Population-Based Study

DA YOUNG LEE, JI HEE YU, KYUNGDO HAN, JI A SEO, NAN HEE KIM

Diabetes 2019;68(Supplement_1):17-LB

https://doi.org/10.2337/db19-17-LB

Published: 01 June 2019

View article titled, 17-LB: Prognostic Value of Gamma-Glutamyl Transferase Variability in Individuals with Diabetes: A Nationwide Population-Based Study

Meeting Abstracts

1163-P: Comparison of Glycemic Variability between Gemigliptin and Dapagliflozin in Patients with Type 2 Diabetes Mellitus: A Randomized, Active-Controlled, Multicenter, 12-Week Clinical Trial (STABLE II Study)

YOU CHEOL HWANG, JAE HYEON KIM, SOO HEON KWAK, SANGYONG KIM, JONG CHUL WON, JI CHEOL BAE, HYUN JIN KIM, SUNGHWAN SUH, EUN YOUNG LEE, SUBIN LEE

Diabetes 2019;68(Supplement_1):1163-P

https://doi.org/10.2337/db19-1163-P

Published: 01 June 2019

View article titled, 1163-P: Comparison of Glycemic Variability between Gemigliptin and Dapagliflozin in Patients with Type 2 Diabetes Mellitus: A Randomized, Active-Controlled, Multicenter, 12-Week Clinical Trial (STABLE II Study)

Meeting Abstracts

636-P: Effect of Obesity and Weight Variations on the Decline of Ankle-Brachial Index in Type 2 Diabetes Subjects without Peripheral Artery Disease

YEOREE YANG, JAYOUNG LIM, EUN YOUNG LEE, KUN-HO YOON, BONG-YUN CHA, SEUNG-HWAN LEE, YUNJUNG CHO

Diabetes 2019;68(Supplement_1):636-P

https://doi.org/10.2337/db19-636-P

Published: 01 June 2019

View article titled, 636-P: Effect of Obesity and Weight Variations on the Decline of Ankle-Brachial Index in Type 2 Diabetes Subjects without Peripheral Artery Disease

Journal Articles

Opposing Effects of Neuropilin-1 and -2 on Sensory Nerve Regeneration in Wounded Corneas: Role of Sema3C in Ameliorating Diabetic Neurotrophic Keratopathy

Patrick Shean-Young Lee, Nan Gao, Mamata Dike, Olga Shkilnyy, Rao Me, Yangyang Zhang, Fu-Shin X. Yu

Diabetes 2019;68(4):807–818

https://doi.org/10.2337/db18-1172

Published: 24 January 2019

View article titled, Opposing Effects of Neuropilin-1 and -2 on Sensory Nerve Regeneration in Wounded Corneas: Role of Sema3C in Ameliorating Diabetic Neurotrophic Keratopathy

Includes: Supplementary data

Meeting Abstracts

Changes in Blood Glucose Levels and Body Weight in Patients Administered Sodium-Glucose Cotransporter 2 Inhibitors

HUN-SUNG KIM, EUN YOUNG LEE, KUN-HO YOON

Diabetes 2018;67(Supplement_1):1167-P

https://doi.org/10.2337/db18-1167-P

Published: 01 July 2018

View article titled, Changes in Blood Glucose Levels and Body Weight in Patients Administered Sodium-Glucose Cotransporter 2 Inhibitors

Meeting Abstracts

Implementation and Evaluation of Gestational Diabetes Management Using Mobile Health Care Service—A Pilot Study

MINKYUNG LEE, CHEOL-YOUNG PARK, SUNG-WOO PARK, DA YOUNG LEE, JI-HEE SUNG

Diabetes 2018;67(Supplement_1):708-P

https://doi.org/10.2337/db18-708-P

Published: 01 July 2018

View article titled, Implementation and Evaluation of Gestational Diabetes Management Using Mobile Health Care Service—A Pilot Study

NARROW

913-P: Risk of Dementia in Diabetes Patients Aged Less than 70 Years Initiating Sodium–Glucose Cotransporter-2 Inhibitor vs. Dipeptidyl-Peptidase-4 Inhibitor

420-P: Effects of Nonalbuminuric Type 2 Diabetes Mellitus on Renal Outcomes

426-P: Association of Succinate and Adenosine Nucleotide Metabolic Pathways with the Progression of Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus

452-P: Risk of Cardiovascular Disease according to Baseline LDL Cholesterol Level in Different Age Groups among 2 Million Diabetes Patients

890-P: Efficacy and Safety of Dapagliflozin Add-on Therapy to Evogliptin plus Metformin Combinations in Inadequately Controlled Patients with Type 2 Diabetes—A 24-Week, Randomized, Double-blind, Placebo-Controlled, Parallel-Design, Phase 3 Trial

253-LB: Characterization of Korean Type 2 Diabetes as Hyperinsulinemic, Insulin-Resistant, and miR-10a/b-5p-Deficient Hyperglycemia

1432-P: Lipid Profile and Visit-to-Visit Variability of LDL Cholesterol, the Association with Risk of Young-Onset Type 2 Diabetes—Nationwide Retrospective Cohort Study

975-P: Clinical and Lifestyle Determinants of Continuous Glucose Monitoring Metrics in Insulin-Treated Patients with Type 2 Diabetes

765-P: DA-1241, a Novel GPR119 Agonist: Data on Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) from Part 2 of a Phase 1b Multiple Ascending Dose (MAD) Study in Patients with Type 2 Diabetes Mellitus (T2DM)

766-P: DA-1241, a Novel GPR119 Agonist: Data on Safety, Tolerability, and Pharmacokinetics (PK) from Part 1 of a Phase 1b Multiple Ascending Dose (MAD) Study in Healthy Volunteers (HV)

868-P: The Efficacy of Personalized Diabetes Management Using an Electronic Medical Record-Integrated Mobile Application

352-P: Assessment of a Deep Learning Model Based on Three-Year Longitudinal Electronic Health Record Data for Predicting Severe Hypoglycemia in Patients with Type 2 Diabetes

2289-PUB: Comparison of GalT-KO Porcine Islet Xenograft Survival between Microcapsule against Hypoxia and Microcapsule against Fibrosis in Diabetic Mice Model

2176-P: miRNA-374 Improves Glucotoxicity-Induced Beta-Cell Dysfunction and Glucose Metabolism Dysfunction through the Regulation of PGC-1 Alpha

17-LB: Prognostic Value of Gamma-Glutamyl Transferase Variability in Individuals with Diabetes: A Nationwide Population-Based Study

1163-P: Comparison of Glycemic Variability between Gemigliptin and Dapagliflozin in Patients with Type 2 Diabetes Mellitus: A Randomized, Active-Controlled, Multicenter, 12-Week Clinical Trial (STABLE II Study)

636-P: Effect of Obesity and Weight Variations on the Decline of Ankle-Brachial Index in Type 2 Diabetes Subjects without Peripheral Artery Disease

Opposing Effects of Neuropilin-1 and -2 on Sensory Nerve Regeneration in Wounded Corneas: Role of Sema3C in Ameliorating Diabetic Neurotrophic Keratopathy

Changes in Blood Glucose Levels and Body Weight in Patients Administered Sodium-Glucose Cotransporter 2 Inhibitors

Implementation and Evaluation of Gestational Diabetes Management Using Mobile Health Care Service—A Pilot Study

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only